This compound is a pharmaceutical intermediate featuring a thiophene core with fluorine, nitro, and carboxylate substituents, intended for use in chemical synthesis for pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2636079-30-4
3-Thiophenecarboxylic acid, 2-[[(2,6-difluorophenyl)methyl][(1-methylethoxy)carbonyl]amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester
pharmaceutical intermediate
2-{[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino}-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)thiophene-3-carboxylic acid
pharmaceutical intermediate for relugolix
4,4-Azobis(4-cyanovaleric acid)
free radical initiator
2-cyano-N,N-diethylacetamide
Pharmaceutical intermediate
(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic Acid
Pharmaceutical intermediate for finerenone
2-Cyanoethyl (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate for finerenone
Ethyl 2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)-3-thiophenecarboxylate
pharmaceutical intermediate
Ethyl 4-(bromomethyl)-2-[(2,6-difluorophenyl)methyl-ethoxycarbonylamino]-5-(4-nitrophenyl)thiophene-3-carboxylate
pharmaceutical intermediate
2-[(2,6-difluorophenyl)methyl-propan-2-yloxycarbonylamino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)thiophene-3-carboxylic acid
PYBXIKLKVQJMRN-UHFFFAOYSA-N
CC(C)OC(=O)N(CC1=C(C=CC=C1F)F)C2=C(C(=C(S2)C3=CC=C(C=C3)[N+](=O)[O-])CN(C)C)C(=O)O
—